Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Magdalena Samborska"'
Autor:
Katarzyna Pawińska-Wąsikowska, Małgorzata Czogała, Karolina Bukowska-Strakova, Marta Surman, Monika Rygielska, Teofila Książek, Beata Sadowska, Agnieszka Pac, Jolanta Skalska-Sadowska, Magdalena Samborska, Jacek Wachowiak, Małgorzata Ciebiera, Radosław Chaber, Renata Tomaszewska, Tomasz Szczepański, Karolina Zielezińska, Tomasz Urasiński, Anna Rodziewicz-Konarska, Krzysztof Kałwak, Marta Kozłowska, Ninela Irga-Jaworska, Barbara Sikorska-Fic, Bartosz Chyżyński, Paweł Łaguna, Katarzyna Muszyńska-Rosłan, Maryna Krawczuk-Rybak, Paulina Deleszkiewicz, Katarzyna Drabko, Katarzyna Bobeff, Wojciech Młynarski, Agnieszka Chodała-Grzywacz, Grażyna Karolczyk, Katarzyna Mycko, Wanda Badowska, Natalia Bartoszewicz, Jan Styczyński, Katarzyna Machnik, Weronika Stolpa, Agnieszka Mizia-Malarz, Walentyna Balwierz, Szymon Skoczeń
Publikováno v:
Frontiers in Pediatrics, Vol 12 (2024)
BackgroundA personalised approach to the treatment of acute myeloid leukemia (AML) in children and adolescents, as well as the development of supportive therapies, has significantly improved survival. Despite this, some patients still die before star
Externí odkaz:
https://doaj.org/article/5ff981bb50e347aeb53dd036a007a151
Autor:
Katarzyna Pawinska-Wasikowska, Malgorzata Czogala, Szymon Skoczen, Marta Surman, Monika Rygielska, Teofila Ksiazek, Agnieszka Pac, Aleksandra Wieczorek, Jolanta Skalska-Sadowska, Magdalena Samborska, Jacek Wachowiak, Radoslaw Chaber, Renata Tomaszewska, Tomasz Szczepanski, Karolina Zielezinska, Tomasz Urasinski, Malgorzata Moj-Hackemer, Krzysztof Kalwak, Marta Kozlowska, Ninela Irga-Jaworska, Walentyna Balwierz, Karolina Bukowska-Strakova
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
BackgroundGemtuzumab ozogamicin (GO), one of the first targeted drugs used in oncology, consists of an anti-cluster of differentiation 33 (CD33) monoclonal antibody bound to a derivative of cytotoxic calicheamicin. After the drug withdrawn in 2010 du
Externí odkaz:
https://doaj.org/article/4f6992bae96b4263b3d4ca86cbcc89e8
Autor:
Magdalena Samborska, Małgorzata Barańska, Jacek Wachowiak, Jolanta Skalska-Sadowska, Sheanda Thambyrajah, Małgorzata Czogała, Walentyna Balwierz, Sylwia Kołtan, Katarzyna Peszyńska-Żelazny, Mariusz Wysocki, Tomasz Ociepa, Tomasz Urasiński, Grażyna Wróbel, Jadwiga Węcławek-Tompol, Bogna Ukielska, Alicja Chybicka, Anna Kitszel, Maryna Krawczuk-Rybak, Anna Szmydki-Baran, Iwona Malinowska, Michał Matysiak, Agnieszka Mizia-Malarz, Renata Tomaszewska, Tomasz Szczepański, Agnieszka Chodała-Grzywacz, Grażyna Karolczyk, Lucyna Maciejka-Kembłowska, Ninela Irga-Jaworska, Wanda Badowska, Michał Dopierała, Paweł Kurzawa, Katarzyna Derwich
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
IntroductionMyeloid sarcoma (MS) is an extramedullary malignant tumor composed of immature myeloid cells. It occurs in patients with acute myeloid leukemia (AML), myelodysplastic syndrome (MDS), or chronic myeloid leukemia (CML). MS may coincide with
Externí odkaz:
https://doaj.org/article/c780c7e5d24c4e5c8027a70500579cf7
Autor:
Katarzyna Bobeff, Agata Pastorczak, Zuzanna Urbanska, Walentyna Balwierz, Edyta Juraszewska, Jacek Wachowiak, Katarzyna Derwich, Magdalena Samborska, Krzysztof Kalwak, Iwona Dachowska-Kalwak, Paweł Laguna, Iwona Malinowska, Katarzyna Smalisz, Jolanta Gozdzik, Aleksandra Oszer, Bartosz Urbanski, Maciej Zdunek, Tomasz Szczepanski, Wojciech Mlynarski, Szymon Janczar
Publikováno v:
Children, Vol 10, Iss 4, p 745 (2023)
Venetoclax, the best established BH3-mimetic, is a practice-changing proapoptotic drug in blood cancers in adults. In paediatrics the data are fewer but exciting results were recently presented in relapsed or refractory leukaemias demonstrating signi
Externí odkaz:
https://doaj.org/article/98a8dfe4a61d4af7bc0b568d64fad2c4
Autor:
Magdalena Samborska, Katarzyna Derwich, Jolanta Skalska-Sadowska, Paweł Kurzawa, Jacek Wachowiak
Publikováno v:
Contemporary Oncology, Vol 20, Iss 6, Pp 444-448 (2017)
Myeloid sarcoma (MS) is a malignant extramedullary tumour, which consists of immature cells of myeloid origin. It may occur de novo , concurrently or precede the diagnosis of acute myeloid leukemia (AML), myelodysplastic syndrome (MDS) or chronic mye
Externí odkaz:
https://doaj.org/article/48e2e4f3e86446b6bb0f36ddefdc6197
Autor:
Katarzyna Derwich, Paweł Kurzawa, Magdalena Samborska, Jacek Wachowiak, Jolanta Skalska-Sadowska
Publikováno v:
Contemporary Oncology, Vol 20, Iss 6, Pp 444-448 (2017)
Contemporary Oncology
Contemporary Oncology
Myeloid sarcoma (MS) is a malignant extramedullary tumour, which consists of immature cells of myeloid origin. It may occur de novo , concurrently or precede the diagnosis of acute myeloid leukemia (AML), myelodysplastic syndrome (MDS) or chronic mye
Autor:
Jolanta, Skalska-Sadowska, Danuta, Januszkiewicz-Lewandowska, Katarzyna, Derwich, Anna, Pieczonka, Magdalena, Samborska, Jacek, Wachowiak
Publikováno v:
Pediatric bloodcancer. 62(6)
Few patients in remission of Ph-positive chronic myelogenous leukemia (CML) develop Ph-negative MDS/AML, usually with clonal cytogenetic abnormalities. Isolated Ph-negative myeloid sarcoma (MS) is presented here as a form of such disorder, different
Publikováno v:
Scopus-Elsevier
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::819264f1c43b2ec709c710ad5550b367
http://www.scopus.com/inward/record.url?eid=2-s2.0-69949161153&partnerID=MN8TOARS
http://www.scopus.com/inward/record.url?eid=2-s2.0-69949161153&partnerID=MN8TOARS